ClinicalTrials.govpublic full text
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
hormone receptor positive, her2-negative, advanced breast cancer, advanced breast cancer, hormone receptor positive, her2-negative, lee011,, letrozole, tamoxifen, fulvestrant, postmenopausal asian women, pre and postmenopausal japanese women, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1008650
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.